Skip to content

Real-time Amino acid Profiling 2

Real-time Amino acid Profiling 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28579
Enrollment
12
Registered
2020-09-21
Start date
2020-11-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Digestion Kinetics

Interventions

All subjects in this study, will consume different (blends of) dairy protein n small serving size with different energy contents with whey and casein as reference products.

Sponsors

FrieslandCampina Nederland BV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Age =65 and =80 • BMI =20 and =32 kg/m2 • Non-smoking • Healthy as assessed by the NIZO lifestyle and health questionnaire (“Verklaring leefgewoonten en gezondheid”) and according to the judgment of the study physician. • Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health questionnaire (3 main meals per day) • Veins suitable for cannulation (blood sampling) • Voluntary participation • Having given written informed consent • Willing to comply with study procedures • Accept use of all encoded data, including publication, and the confidential use and storage of all data for 15 years. • Accept disclosure of the financial benefit of participation in the study to the authorities concerned

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Participation in any clinical trial including blood sampling and/or administration of substances up to 30 days before day 1 of this study • Having a history of medical or surgical events that may significantly affect the study outcome, including: Inflammatory bowel disease, hepatitis, pancreatitis, ulcers, gastrointestinal or rectal bleeding; major gastrointestinal tract surgery such as gastrectomy, gastroenterostomy, or bowel resection; known or suspected gastrointestinal disorders, colon or GI tract cancer • Use of the following medication: glucose lowering drugs, insulin; medication that may impact gastric emptying (e.g. gastric acid inhibitors or laxatives) • Diagnosed with diabetes, being treated for high blood glucose or increased fasting blood glucose (> 7 mmol/l in finger prick blood) as assessed during screening visit • For men: Hb 28 units/week and >4/day; for women: >21 units/week and >3/day • Reported unexpected weight loss or weight gain of > 3 kg in the month prior to pre-study screening, or intention to lose weight during the study period • Reported slimming or medically prescribed diet • Recent blood donation (<1 month prior to Day 01 of the study) • Not willing to give up blood donation during the study • Personnel of NIZO food research and FrieslandCampina, their partner and their first and second degree relatives • Not having a general practitioner • Not willing to accept information-transfer concerning participation in the study, or information regarding his or her health, like laboratory

Design outcomes

Primary

MeasureTime frame
The primary objective is to investigate postprandial amino acid kinetics in blood after consumption of concentrated protein products in small volumes providing different (blends of) dairy proteins, with different energy content densities in an older population

Secondary

MeasureTime frame
The secondary objectives of the study is to investigate postprandial glucose and insulin kinetics in blood after consumption of concentrated protein products in small volumes providing different (blends of) dairy proteins, with different energy content densities in an older population.

Contacts

Public ContactJoyce Schloesser

NIZO

Joyce.Schloesser@nizo.com0625345167

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)